Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

RAT On Horizon To Manage Facial Eczema On Farm

A rapid antigen test (RAT) aimed at early detection of facial eczema (FE) in ruminants will help manage a disease that costs the New Zealand economy more than $200 million each year.

The Ministry for Primary Industries’ Sustainable Food and Fibre Futures fund is investing more than $35,000 in a project with Tokaora Diagnostics to develop a prototype facial eczema RAT and undertake field testing. The test could be used with sheep, cattle, and deer but initial trials will focus on dairy cattle.

“FE is a disease of the liver and often doesn’t show physical symptoms until it’s too late to save the animal,” says Steve Penno, MPI’s Director of Investment Programmes.

“Currently there’s no cheap, on-farm diagnostic on the market, so we’re supporting Tokaora Diagnostics to take their proof-of-concept test to the next stage.”

Tokaora Diagnostics is a family-owned research company headed by chief researcher Frey Livingston and his mother Pam, who is the managing director. The company conducted initial research and development through start-up grants from Callaghan Innovation. It also won the Venture Taranaki Power Up Awards in 2022 and received mentoring through the Sprout Agritech Accelerator programme.

“We’re grateful to have received so much support to make an ‘invisible’ problem visible,” says Frey Livingston.

“Right now, farmers can test for the disease through blood samples taken by vets but it is expensive and time consuming. With our solution, farmers will be able to do the testing themselves quickly and easily via nasal mucus or saliva.”

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

Financial losses from FE in New Zealand have been estimated as high as $274 million per year from lost production, and the cost of labour, treatment, and deceased animals.

“By detecting facial eczema accurately we’d expect to see significant cost savings on farms in affected areas,” says Pam Livingston.

“It will enable farmers to surveillance test, which will facilitate timely treatment. It will also allow more informed purchasing, breeding, and culling decisions. For vets, it will be a quick diagnostic tool when called to a poorly animal, and for researchers it will give a timely answer to the ‘who has it and how badly’ question. And, of course, improved animal welfare is a high priority.”

“FE is a long-standing issue for our agricultural sector, and with climate change it’s expected to get worse as the toxic spores that cause the disease are more likely to grow in warm and humid conditions,” says Steve Penno.

“MPI has invested in a range of projects aimed at combating FE, including breeding spore-resistant grass, and working with vets, dairy farmers, and rural professionals to raise awareness about how to take preventative action.

“This project is another step towards better managing this disease.”

For further information on the project contact Pam Livingston at pam@tokaoradiagnostics.nz

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.